Request a document copy: Real-World Comparison of Major Bleeding Risk Among Untreated Non-Valvular Atrial Fibrillation Patients and Those Initiating Apixaban, Dabigatran, Rivaroxaban, or Warfarin

all files (of this document) in restricted access
the file(s) you requested
Cancel